Springer Nature is making Coronavirus research free. View research | View latest news | Sign up for updates

Characteristics of patients diagnosed with renal vein thrombosis and glomerulopathy: a case series

  • 261 Accesses



Few contemporary studies have evaluated the clinical characteristics of patients with biopsy-proven glomerulopathy diagnosed with renal vein thrombosis (RVT).


Retrospective case series study within an integrated health system in a 12-year period (January 1, 2000 through December 31, 2011) investigating clinical characteristics of all adult patients who underwent native or transplant kidney biopsy and also had a diagnosis of RVT. Patient characteristics, diagnostic studies, and outcomes were evaluated.


Among 3763 eligible patients, 17 had imaging confirmed RVT. Of these, 15 had membranous nephropathy (idiopathic or secondary to autoimmune disease). Although the biopsy population included primary and secondary glomerular disease patients, all 17 RVT patients had severe nephrotic syndrome and profound hypoalbuminemia with mean (SD) of albumin: 1.5 g/dL (0.66).


Clinically significant RVT in patients with glomerulopathy appears to be a rather rare entity, occurring predominantly in patients with severe nephrotic syndrome due to idiopathic membranous nephropathy and membranous nephropathy secondary to autoimmune disease.

This is a preview of subscription content, log in to check access.

Fig. 1


  1. 1.

    Brenner BM, Rector FC (2008) Brenner and Rector’s the kidney. Saunders Elsevier, Philadelphia, pp 1165–1169

  2. 2.

    Wysokinski WE, Gosk-Bierska I, Greene EL, Grill D, Wiste H, McBane RD II (2008) Clinical characteristics and long-term follow-up of patients with renal vein thrombosis. Am J Kidney Dis 51(2):224–232. doi:10.1053/j.ajkd.2007.10.030

  3. 3.

    Loscalzo J (2013) Venous thrombosis in the nephrotic syndrome. New Engl J Med 368(10):956–958. doi:10.1056/NEJMcibr1209459

  4. 4.

    Hanevold CD, Lazarchick J, Constantin MA, Hiott KL, Orak JK (1996) Acquired free protein S deficiency in children with steroid resistant nephrosis. Ann Clin Lab Sci 26(3):279–282

  5. 5.

    Al-Mugeiren MM, Gader AM, Al-Rasheed SA, Bahakim HM, Al-Momen AK, Al-Salloum A (1996) Coagulopathy of childhood nephrotic syndrome—a reappraisal of the role of natural anticoagulants and fibrinolysis. Haemostasis 26(6):304–310

  6. 6.

    Schlegel N (1997) Thromboembolic risks and complications in nephrotic children. Semin Thromb Hemost 23(3):271–280. doi:10.1055/s-2007-996100

  7. 7.

    Eddy AA, Symons JM (2003) Nephrotic syndrome in childhood. Lancet 362(9384):629–639. doi:10.1016/S0140-6736(03)14184-0

  8. 8.

    Mahmoodi BK, ten Kate MK, Waanders F, Veeger NJ, Brouwer JL, Vogt L, Navis G, van der Meer J (2008) High absolute risks and predictors of venous and arterial thromboembolic events in patients with nephrotic syndrome: results from a large retrospective cohort study. Circulation 117(2):224–230. doi:10.1161/CIRCULATIONAHA.107.716951

  9. 9.

    Colle JP, Mishal Z, Lesty C, Mirshahi M, Peyne J, Baumelou A, Bensman A, Soria J, Soria C (1999) Abnormal fibrin clot architecture in nephrotic patients is related to hypofibrinolysis: influence of plasma biochemical modifications: a possible mechanism for the high thrombotic tendency? Thromb Haemost 82(5):1482–1489

  10. 10.

    Nickolas TL, Radhakrishnan J, Appel GB (2003) Hyperlipidemia and thrombotic complications in patients with membranous nephropathy. Semin Nephrol 23(4):406–411

  11. 11.

    Chugh KS, Malik N, Uberoi HS, Gupta VK, Aggarwal ML, Singhal PC, Suri S, Jain SK (1981) Renal vein thrombosis in nephrotic syndrome—a prospective study and review. Postgrad Med J 57(671):566–570

  12. 12.

    Llach F, Papper S, Massry SG (1980) The clinical spectrum of renal vein thrombosis: acute and chronic. Am J Med 69(6):819–827

  13. 13.

    Velasquez Forero F, Garcia Prugue N, Ruiz Morales N (1988) Idiopathic nephrotic syndrome of the adult with asymptomatic thrombosis of the renal vein. Am J Nephrol 8(6):457–462

  14. 14.

    Wagoner RD, Stanson AW, Holley KE, Winter CS (1983) Renal vein thrombosis in idiopathic membranous glomerulopathy and nephrotic syndrome: incidence and significance. Kidney Int 23(2):368–374

  15. 15.

    Koebnick C, Langer-Gould AM, Gould MK, Chao CR, Iyer RL, Smith N, Chen W, Jacobsen SJ (2012) Sociodemographic characteristics of members of a large, integrated health care system: comparison with US Census Bureau data. Perm J 16(3):37–41

  16. 16.

    Sim JJ, Batech M, Hever A, Harrison TN, Avelar T, Kanter MH, Jacobsen SJ (2016) Distribution of biopsy-proven presumed primary glomerulonephropathies in 2000–2011 among a racially and ethnically diverse US population. Am J Kidney Dis. doi:10.1053/j.ajkd.2016.03.416

  17. 17.

    Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D, Modification of Diet in Renal Disease Study Group (1999) A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Ann Intern Med 130(6):461–470

  18. 18.

    Barbour SJ, Greenwald A, Djurdjev O, Levin A, Hladunewich MA, Nachman PH, Hogan SL, Cattran DC, Reich HN (2012) Disease-specific risk of venous thromboembolic events is increased in idiopathic glomerulonephritis. Kidney Int 81(2):190–195. doi:10.1038/ki.2011.312

  19. 19.

    Asghar M, Ahmed K, Shah SS, Siddique MK, Dasgupta P, Khan MS (2007) Renal vein thrombosis. Eur J Vasc Endovasc Surg 34(2):217–223. doi:10.1016/j.ejvs.2007.02.017

  20. 20.

    Rahmouni A, Jazaerli N, Radier C, Mathieu D, Vasile N, Ben Maadi A, Lang P, Weil B, Rostoker G (1994) Evaluation of magnetic resonance imaging for the assessment of renal vein thrombosis in the nephrotic syndrome. Nephron 68(2):271–272

  21. 21.

    Avasthi PS, Greene ER, Scholler C, Fowler CR (1983) Noninvasive diagnosis of renal vein thrombosis by ultrasonic echo-Doppler flowmetry. Kidney Int 23(6):882–887

  22. 22.

    Tempany CM, Morton RA, Marshall FF (1992) MRI of the renal veins: assessment of nonneoplastic venous thrombosis. J Comput Assist Tomogr 16(6):929–934

  23. 23.

    Wei LQ, Rong ZK, Gui L, Shan RD (1991) CT diagnosis of renal vein thrombosis in nephrotic syndrome. J Comput Assist Tomogr 15(3):454–457

  24. 24.

    Zhang LJ, Zhang Z, Li SJ, Meinel FG, Nance JW Jr, Zhou CS, Zhao YE, Schoepf UJ, Lu GM (2014) Pulmonary embolism and renal vein thrombosis in patients with nephrotic syndrome: prospective evaluation of prevalence and risk factors with CT. Radiology 273(3):897–906. doi:10.1148/radiol.14140121

  25. 25.

    Kayali F, Najjar R, Aswad F, Matta F, Stein PD (2008) Venous thromboembolism in patients hospitalized with nephrotic syndrome. Am J Med 121(3):226–230. doi:10.1016/j.amjmed.2007.08.042

  26. 26.

    Lionaki S, Derebail VK, Hogan SL, Barbour S, Lee T, Hladunewich M, Greenwald A, Hu Y, Jennette CE, Jennette JC, Falk RJ, Cattran DC, Nachman PH, Reich HN (2012) Venous thromboembolism in patients with membranous nephropathy. Clin J Am Soc Nephrol 7(1):43–51. doi:10.2215/CJN.04250511

  27. 27.

    Bellomo R, Atkins RC (1993) Membranous nephropathy and thromboembolism: is prophylactic anticoagulation warranted? Nephron 63(3):249–254

  28. 28.

    Lee T, Biddle AK, Lionaki S, Derebail VK, Barbour SJ, Tannous S, Hladunewich MA, Hu Y, Poulton CJ, Mahoney SL, Charles Jennette J, Hogan SL, Falk RJ, Cattran DC, Reich HN, Nachman PH (2014) Personalized prophylactic anticoagulation decision analysis in patients with membranous nephropathy. Kidney Int 85(6):1412–1420. doi:10.1038/ki.2013.476

  29. 29.

    Glassock RJ (2007) Prophylactic anticoagulation in nephrotic syndrome: a clinical conundrum. J Am Soc Nephrol 18(8):2221–2225. doi:10.1681/ASN.2006111300

  30. 30.

    de Groot PG, Urbanus RT (2012) The significance of autoantibodies against beta 2-glycoprotein I. Blood 120(2):266–274. doi:10.1182/blood-2012-03-378646

  31. 31.

    Lai NS, Lan JL (1997) Renal vein thrombosis in Chinese patients with systemic lupus erythematosus. Ann Rheum Dis 56(9):562–564

Download references


This study was funded in part by the Kaiser Permanente Southern California Clinical Investigator Award and by an investigator initiated research Grant (JJS PI) from Autoimmune and Rare Diseases of Mallinckrodt Pharmaceuticals.

Author information

Correspondence to John J. Sim.

Ethics declarations

Conflict of interest

John J. Sim has received research Grants from Mallinckrodt Pharmaceuticals, Keryx Pharmaceuticals, Sanofi Aventis Pharmaceuticals, and Otsuka Pharmaceuticals. No other authors have any conflict of interest to declare.

Ethical approval

All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards. This article does not contain any studies with animals performed by any of the authors.

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Ross, O., Pourmoussa, A., Batech, M. et al. Characteristics of patients diagnosed with renal vein thrombosis and glomerulopathy: a case series. Int Urol Nephrol 49, 285–293 (2017).

Download citation


  • Renal vein thrombosis
  • Nephrotic syndrome
  • Membranous nephropathy